12:00 AM
Jun 17, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Rhizen preclinical data

In rats and mice with airway disorders, RP6503 inhibited pulmonary neutrophilia and proinflammatory cell infiltration, respectively. In rats, RP6503 displayed <10% oral bioavailability...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >